LETTER TO THE EDITOR
Sulfate reducing gut bacteria and Parkinson's disease
First published: 03 November 2020
No abstract is available for this article.
REFERENCES
- 1Kang X, Ploner A, Ludvigsson JF, et al. Clostridium difficile infection and risk of Parkinson’s disease: a Swedish population-based cohort study. Eur J Neurol. 2020; 27: 2134-2141.
- 2Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbiological pathways in colonic sulfur metabolism and links with health and disease. Front Physiol. 2012; 3: 448.
- 3Hertel J, et al. Integrated analyses of microbiome and longitudinal metabolome reveal microbial-host interactions on sulfur metabolism in Parkinson’s disease. Cell Rep. 2019; 2: 1767-1777.
- 4Guo Z, Li C, Wang CM, Xie YJ. CSE/H2S system protects mesenchymal stem cells from hypoxia and serum deprivation-induced apoptosis via mitochondrial injury, endoplasmic reticulum stress and PI3K/Akt atctivation pathways. Mol Med Rep. 2015; 12: 21228-22134.
- 5Kumar A, Gannini D, Mason RP. Role of cytochrome c in α-synuclein radical formation: implication of α-synuclein in neuronal death in Maneb- and paraquat-induced model of Parkinson’ disease. Mol Neurodegener. 2016; 11: 70.
